tiprankstipranks
IQVIA Holdings Inc (IQV)
NYSE:IQV
US Market
Want to see IQV full AI Analyst Report?

IQVIA Holdings (IQV) Earnings Dates, Call Summary & Reports

1,044 Followers

Earnings Data

Report Date
Jul 28, 2026
Before Open (Confirmed)
Period Ending
2026 (Q2)
Consensus EPS Forecast
3.03
Last Year’s EPS
2.81
Same Quarter Last Year
Based on 10 Analysts Ratings

Earnings Call Summary

Q1 2026
Earnings Call Date:May 05, 2026|
% Change Since:
|
Earnings Call Sentiment|Positive
The call conveyed broad strength: record revenue, EPS beat, double-digit bookings growth in R&D Solutions, accelerating organic growth in both Commercial and R&D segments, strong free cash flow and share repurchases, meaningful customer wins and rapid AI adoption. Near-term caveats included unusually low pass-throughs that depressed a headline book-to-bill metric, a ~60 bps EBITDA margin contraction driven by FX and mix, and elevated net leverage (3.62x). Management reaffirmed revenue and EBITDA guidance and raised EPS guidance. On balance, the positives materially outweigh the negatives.
Company Guidance
IQVIA reaffirmed full‑year 2026 revenue guidance of $17.15–$17.35 billion (growth 5.2%–6.4%, 5.8% at the midpoint), assuming roughly 150 basis points from acquisitions and ~100 basis points of FX tailwind, and reiterated adjusted EBITDA guidance of $4.05–$4.25 billion (growth 4.9%–6.3%, 5.6% midpoint), while raising adjusted diluted EPS to $12.65–$12.95 (up 6.1%–8.6%, 7.4% midpoint); for Q2 they guide revenue of $4.28–$4.34 billion (up 6.5%–8%), adjusted EBITDA of $955–$975 million (up 4.9%–7.1%) and adjusted diluted EPS of $2.98–$3.08 (up 6%–9.6%), with all guidance assuming foreign exchange rates as of May 4 persist for the balance of the year.
Record Q1 Revenue and EPS Beat
Total Q1 revenue of $4.151 billion, up 8.4% year over year (6.0% at constant currency); adjusted diluted EPS of $2.90, up 7.4% year over year, both exceeding the high end of guidance.
Segment Revenue Strength
Commercial Solutions revenue of $1.754 billion, up 11.6% reported (8.5% constant currency); R&D Solutions revenue of $2.397 billion, up 6.2% reported (4.2% constant currency).
Adjusted EBITDA and Profitability
Adjusted EBITDA of $932 million, up 5.5% year over year; adjusted net income of $492 million; free cash flow of $491 million (100% of adjusted net income), a 15% increase year over year.
Strong Bookings and Backlog
R&D Solutions net new bookings of $2.5 billion, a double-digit increase year over year; total backlog of $34.2 billion (mid single-digit YoY growth) with $8.9 billion expected to convert to revenue in the next 12 months (high single-digit YoY growth).
Raised and Reaffirmed Guidance
Reaffirmed full-year 2026 revenue guidance of $17.15B–$17.35B (5.2%–6.4% growth) and adjusted EBITDA guidance of $4.05B–$4.25B; raised full-year adjusted diluted EPS guidance to $12.65–$12.95 (up 6.1%–8.6%).
Strong Q2 Outlook
Q2 guidance: revenue $4.28B–$4.34B (6.5%–8.0% YoY growth), adjusted EBITDA $955M–$975M (4.9%–7.1% YoY growth), adjusted diluted EPS $2.98–$3.08 (6.0%–9.6% YoY growth).
Material AI Progress and Adoption
Unveiled iqvia.ai and deployed 192 AI agents across 64 use cases; 19 of the top 20 pharma companies using IQVIA agents; AI cited as a driver of increased client demand and larger pipelines.
Notable Client Wins and Strategic Partnerships
Multiple multiyear and strategic wins: Pfizer regional promotion agreement (23 European countries), Boehringer Ingelheim global commercial intelligence collaboration (59 countries), top-five/top-10 pharma AI-enabled clinical and safety deals, partnership with Duke Clinical Research Institute in obesity; several EVP and patient analytics mandates.
Share Repurchase and Cash Position
Repurchased $552 million of shares in Q1; cash and cash equivalents $1.947 billion with approximately $1.2 billion of repurchase authorization remaining.
Acceleration in Organic Growth
Commercial Solutions organic growth accelerated to ~5% (roughly double last year) and R&D Solutions organic growth to ~3% (roughly triple last year), indicating improving underlying momentum.

IQVIA Holdings (IQV) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

IQV Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Jul 28, 2026
2026 (Q2)
3.03 / -
2.81
May 05, 2026
2026 (Q1)
2.82 / 2.90
2.77.41% (+0.20)
Feb 05, 2026
2025 (Q4)
3.40 / 3.42
3.129.62% (+0.30)
Oct 28, 2025
2025 (Q3)
2.98 / 3.00
2.845.63% (+0.16)
Jul 22, 2025
2025 (Q2)
2.77 / 2.81
2.646.44% (+0.17)
May 06, 2025
2025 (Q1)
2.63 / 2.70
2.546.30% (+0.16)
Feb 06, 2025
2024 (Q4)
3.11 / 3.12
2.849.86% (+0.28)
Oct 31, 2024
2024 (Q3)
2.82 / 2.84
2.4914.06% (+0.35)
Jul 22, 2024
2024 (Q2)
2.56 / 2.64
2.438.64% (+0.21)
May 02, 2024
2024 (Q1)
2.49 / 2.54
2.453.67% (+0.09)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed

IQV Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Feb 05, 2026
$202.54$180.96-10.65%
Oct 28, 2025
$217.43$218.13+0.32%
Jul 22, 2025
$158.96$187.38+17.88%
May 06, 2025
$152.30$146.20-4.01%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does IQVIA Holdings Inc (IQV) report earnings?
IQVIA Holdings Inc (IQV) is schdueled to report earning on Jul 28, 2026, Before Open (Confirmed).
    What is IQVIA Holdings Inc (IQV) earnings time?
    IQVIA Holdings Inc (IQV) earnings time is at Jul 28, 2026, Before Open (Confirmed).
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is IQV EPS forecast?
          IQV EPS forecast for the fiscal quarter 2026 (Q2) is 3.03.